VBI Vaccines Inc (VBV):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:VBI Vaccines Inc (VBV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8010
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
VBI Vaccines Inc (VBI), a subsidiary of SciVac Therapeutics Inc is a biopharmaceutical company that discovers and develops novel vaccines for the treatment of immuno-oncology and infectious diseases. The company’s pipeline vaccine candidates include cytomegalovirus; glioblastoma multiforme and zika virus. It utilizes technologies such as eVLP platform, and thermostable platform to develop the vaccine candidates. VBI offers Sci-B-Vac, a hepatitis B vaccine which consists of surface antigens of hepatitis B virus and is free of any next-generation adjuvant. The company operates through its research facilities located in Ottawa, Canada; and a manufacturing facility in Rehovot, Israel. VBI is headquartered in Cambridge, Massachusetts, the US.

VBI Vaccines Inc (VBV) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
VBI Vaccines Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
VBI Vaccines Inc, Medical Devices Deals, 2012 to YTD 2018 10
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Variation Biotech Raises US$1.5 Million In Venture Financing 13
Variation Biotech Raised US$1.4 Million In Venture Financing 14
Variation Biotech Raises US$0.25 Million In Venture Financing 15
Variation Biotech Raises US$0.8 Million In Venture Financing 16
Variation Biotech Raises Additional US$1.2 Million In Venture Financing 17
VBI Vaccines Inc – Key Employees 19
VBI Vaccines Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Jul 26, 2018: VBI Vaccines Announces Second Quarter 2018 Financial Results and Provides Corporate Update 21
May 01, 2018: VBI Vaccines Reports First Quarter 2018 Financial Results 23
Corporate Communications 25
Sep 26, 2018: VBI Vaccines announces formation of new scientific and clinical advisory boards 25
Aug 15, 2018: VBI Vaccines appoints Christopher McNulty as chief financial officer and head of business development 27
Mar 12, 2018: VBI Vaccines Announces Voluntary Delisting from the Toronto Stock Exchange 28
Jan 26, 2018: VBI Vaccines Announces Changes to its Board of Directors 29
Nov 02, 2017: VBI Vaccines Strengthens Board of Directors with Appointment of Ran Nussbaum 30
Government and Public Interest 31
May 31, 2017: Researchers Explore the Possible Link between CMV Infection, Obesity, and Metabolic Syndrome 31
Product News 32
11/10/2017: VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at SITC 2017 32
04/17/2018: VBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients 33
04/05/2017: VBI Vaccines to Present Update on VBI-1901 at the World Vaccine Congress 34
02/07/2017: VBI Vaccines Receives Positive EMA Scientific Advice Regarding Sci-B-Vac Phase III Clinical Study 35
01/17/2018: VBI Vaccines Announces Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901 36
Product Approvals 37
Aug 15, 2017: VBI Vaccines Announces FDA Acceptance of Investigational New Drug Application for VBI-1901 to Treat Glioblastoma Multiforme 37
Clinical Trials 38
Oct 11, 2017: VBI Vaccines to Present Phase 1 CMV vaccine data at The World Vaccine Congress Europe 2017 in Barcelona 38
Oct 11, 2017: VBI Vaccines to Present preclinical Zika vaccine data at The World Vaccine Congress Europe 2017 in Barcelona 39
Aug 28, 2017: VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at The Immuno-Oncology Summit 40
Jul 27, 2017: VBI Vaccines Announces Positive Interim Data from Phase 1 Study of Preventative CMV Vaccine 41
May 02, 2017: VBI Vaccines Provides Update on its Congenital CMV Phase I Clinical Study 42
Feb 22, 2017: VBI Vaccines Receives Positive Response from Health Canada’s Initial Evaluation of the Proposed Sci-B-Vac Phase III Clinical Program 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
VBI Vaccines Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
VBI Vaccines Inc, Deals By Therapy Area, 2012 to YTD 2018 9
VBI Vaccines Inc, Medical Devices Deals, 2012 to YTD 2018 10
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Variation Biotech Raises US$1.5 Million In Venture Financing 13
Variation Biotech Raised US$1.4 Million In Venture Financing 14
Variation Biotech Raises US$0.25 Million In Venture Financing 15
Variation Biotech Raises US$0.8 Million In Venture Financing 16
Variation Biotech Raises Additional US$1.2 Million In Venture Financing 17
VBI Vaccines Inc, Key Competitors 18
VBI Vaccines Inc, Key Employees 19
VBI Vaccines Inc, Other Locations 20
VBI Vaccines Inc, Subsidiaries 20

List of Figures
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
VBI Vaccines Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[VBI Vaccines Inc (VBV):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gastar Exploration Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Gastar Exploration Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Gastar Exploration Inc (Gastar), formerly Gastar Exploration Ltd, is an energy company that offers exploration and development programs. The company explores, develops and produces natural gas …
  • UTC Engenharia SA:企業の戦略的SWOT分析
    UTC Engenharia SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Ranhill Holdings Berhad (RANHILL):企業の財務・戦略的SWOT分析
    Ranhill Holdings Berhad (RANHILL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • West African Development Bank:電力:M&Aディール及び事業提携情報
    Summary West African Development Bank (BOAD) is a public financial institution focused on the balanced development of its member countries of the West African Monetary Union (WAMU). The institution offers financial advisory services; guarantees of bond loans; financial assistance in project preparat …
  • Massachusetts Eye and Ear Infirmary-製薬・医療分野:企業M&A・提携分析
    Summary Massachusetts Eye and Ear Infirmary (MEE) is a healthcare service provider that offers primary, medical and surgical care services. The hospital offers services through departments such as ophthalmology, otolaryngology and patient care services. Its patient care services include patient educ …
  • CJ Corp (001040):企業の財務・戦略的SWOT分析
    CJ Corp (001040) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sanochemia Pharmazeutika AG (SAC)-製薬・医療分野:企業M&A・提携分析
    Summary Sanochemia Pharmazeutika AG (Sanochemia) is a specialty pharmaceutical company that develops and manufactures of innovative drugs in selected indication areas such as neurodegeneration, pain and cancer, as well as diagnostic products based on contrast media. The company’s product portfolio i …
  • Pudumjee Paper Products Limited:企業の戦略・SWOT・財務情報
    Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report Summary Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • PT Energi Mega Persada Tbk (ENRG):石油・ガス:M&Aディール及び事業提携情報
    Summary PT Energi Mega Persada Tbk (EMP) is an upstream oil and gas company that acquires, explores, develops and produces oil and gas from its assets. The company offers products such as crude oil and natural gas. It holds interests in a number of oil and gas blocks in Indonesia and Mozambique. EMP …
  • Bioconnect Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Bioconnect Systems, Inc. (Bioconnect) is a medical device company that designs, manufactures and distributes surgical and medical products. The company offers optiflow technology, which is used to provide quick joining vessels. Its technology also provides services such as control over the g …
  • Malayan Flour Mills Berhad:企業の戦略・SWOT・財務分析
    Malayan Flour Mills Berhad - Strategy, SWOT and Corporate Finance Report Summary Malayan Flour Mills Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Stobart Group Ltd (STOB):企業の財務・戦略的SWOT分析
    Stobart Group Ltd (STOB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Leggett & Platt Incorporated:企業のM&A・事業提携・投資動向
    Leggett & Platt Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Leggett & Platt Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • MemorialCare Health System:製薬・医療:M&Aディール及び事業提携情報
    Summary MemorialCare Health System (MemorialCare) is a non-profit health system that offers medical services. The center offers care services such as stroke care, cancer care, rehabilitation and physical therapy, weight-loss surgery, heart and vascular care, breast care, imaging and radiology, labor …
  • Media-Saturn-Holding GmbH:戦略・SWOT・企業財務分析
    Media-Saturn-Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Media-Saturn-Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Nymox Pharmaceutical Corp (NYMX)-医療機器分野:企業M&A・提携分析
    Summary Nymox Pharmaceutical Corp (Nymox) is a biopharmaceutical company that undertakes the research and development of therapeutics and diagnostics devices to target the unmet needs of the aging population. The company markets diagnostic products for measuring tobacco product exposure and for the …
  • Wellington Management Company LLP:企業のM&A・事業提携・投資動向
    Wellington Management Company LLP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wellington Management Company LLP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Teijin Limited:企業のM&A・事業提携・投資動向
    Teijin Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teijin Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Qorvo Inc (QRVO):企業の財務・戦略的SWOT分析
    Qorvo Inc (QRVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Societe Generale S.A.:企業の戦略・SWOT・財務情報
    Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report Summary Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆